News

Scientists led by Sabine Taschner-Mandl, PhD, St. Anna Children’s Cancer Research Institute, and Nikolaus Fortelny, PhD, Paris Lodron University of Salzburg, are the first to analyze bone marrow metastases from childhood tumors of the nervous system using modern single-cell sequencing analysis. It turns out that cancer cells prevent cells in their environment from fighting the tumor – a process that could be reversed with medication. The findings were published in the renowned journal Nature Communications.

The first-ever ITCC Scientific Days concluded with big success!  The Innovative Therapies for Children with Cancer (ITCC) conference brought together leading international experts and researchers in pediatric oncology to discuss the latest advancements, challenges, and opportunities in understanding and treating pediatric cancers.  Exciting breakthroughs were discussed, including a novel treatment approach for high-grade gliomas that

Prof. Florian Grebien, PhD, is eager to understand why some childhood leukemias show poor treatment response and how this can be tackled. To this end, he is now establishing his own team at St. Anna Children’s Cancer Research Institute (St. Anna CCRI). “Prof. Grebien is an outstanding researcher. We have followed his scientific achievements for many years and are very pleased to have been able to recruit him as a Principal Investigator to St. Anna CCRI,” says Prof. Kaan Boztug, MD, Scientific Director of St. Anna CCRI.

“Children are our future. It’s really important to take care of them.” (Vienna, 11.5.2023) Maria Happel in brief: Why she supports the St. Anna Children’s Cancer Research Institute, how she deals with criticism, and what acting in plays has to do with healing the soul. Under the motto of our 35th anniversary “Reaching for the stars”, we

(Vienna, 29.4.2023) Today is International Day of Immunology – a day to raise awareness for the importance of immunology. A recent study from St. Anna Children’s Cancer Research Institute reveals the association between an impaired immune system and the susceptibility to viral infections and cancer in a young patient.

That was the first Panel Discussion – “Reaching for the Stars – We & Science!” (Vienna, 25.04.2023) The new discussion series “Reaching for the Stars – We & Science!” in cooperation with the Wiener Zeitung started last Tuesday with an inspiring exchange between St. Anna CCRI Principal Investigator Caroline Hutter and Science Buster Martin Moder.

Panel Discussion: “Reaching for the Stars – We & Science”  in cooperation with the Wiener Zeitung. Making the impossible possible – and thus reaching for the stars. This is the claim that St. Anna Children’s Cancer Research Institute has successfully realized in its 35 years of existence. With the clear mission of enabling children with

A combination therapy against childhood bone cancer is efficient in living organisms: if the tumor is transplanted into fish larvae and treated with certain drugs, it shrinks significantly or disappears completely. However, the journey will still take a while before these drugs can be applied in children, say Martin Distel, PhD, from St. Anna Children’s Cancer Research Institute and co-authors. The results were published in the journal Cancer Letters.

Today is RARE DISEASE DAY: We are committed to rare disease research!  (Vienna, 28.02.2023) 300 million people worldwide suffer from rare diseases. Today is Rare Disease Day – a day to raise awareness for precisely these diseases. Together with the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, CeMM Research Center for Molecular Medicine of

🎗February 15 is International Childhood Cancer Day. This day stands for the challenges in combating childhood cancer and is a reminder to raise awareness for this devastating disesae.

Dr. Eleni Tomazou, Principal Investigator at St. Anna Children’s Cancer Research Institute (CCRI), wins one of the very hard to get Consolidator Grants of the European Research Council (ERC).

 Congratulations! For the first time, a young researcher at St. Anna CCRI, Cheryl van de Wetering, PhD, has received a fellowship for outstanding young scientists from the Peter and Traudl Engelhorn Foundation.

Congratulations to Kaan Boztug and Irinka Castanon on two new Stand Alone projects funded by the Austrian Science Fund FWF on the topic of rare diseases of the immune system.